EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC-ND 4.0

Prevalence and Characteristics of North American Indigenous Inflammatory Skin Disease: A Systematic Scoping Review

Rachel Asiniwasis iD, Jordanna Roesler, Amira Muftah, Aysha Lukmanji iD, McKenzie Van Eaton iD, Kavya Yatham, Erin Watson, Eric McMullen iD, Gregory Kost, Colton Jensen, Oluwatosin Odeshi, Anna Chacon und 6 weitere

International Journal of Dermatology · 2026-12 · 65 (12) · 2476-2496

DOI: 10.1111/ijd.70470 ↗

Kurz gefasst

Scoping Review in der Zeitschrift International Journal of Dermatology, online erschienen am 25.05.2026. Verfasst von Rachel Asiniwasis und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, University of Saskatchewan, Regina, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Hidradenitis Suppurativa, Indians, North American, Psoriasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammatory skin diseases (CISD) including atopic dermatitis (AD), psoriasis, and hidradenitis suppurativa (HS) are chronic conditions contributing to health inequities. Their burden among North American Indigenous peoples remains poorly characterized. This scoping review assessed Indigenous representation in clinical research, Phase III/IV trials, and practice guidelines on CISD in Canada and the United States, identifying evidence gaps and proposing strategies to enhance inclusion. Following PRISMA‐ScR methodology, MEDLINE, Embase, CINAHL, Cochrane Library, Indigenous‐focused databases, and gray literature were searched from inception to May 2022. Phase III/IV therapeutic trials for AD and psoriasis (2011–2021) were reviewed separately to evaluate reporting of Indigenous participants and North American guidelines were screened for Indigenous considerations. Of 49 studies included, 39% specifically focused on Indigenous populations of primarily pediatric, rural, and remote Canadian cohorts. Prevalence estimates for AD among Indigenous children ranged from 10% to 25%, with frequent comorbid asthma. Data on psoriasis suggested potentially higher morbidity among First Nations populations, while HS evidence was extremely limited. Indigenous representation was minimal in clinical trials (1.3% of total participants reported under Indigenous categories across included Phase III/IV therapeutic trial reports for AD and psoriasis), and only one recent guideline explicitly incorporated Indigenous perspectives. Overall certainty in burden estimates was low, especially for psoriasis and HS. To address these gaps, key recommendations include consistent reporting of Indigenous identity, setting recruitment targets in trials, supporting Indigenous‐led cohorts and registries, and integrating Indigenous and remote care expertise into guidelines. Advancing CISD research and clinical equity requires alignment with Indigenous data sovereignty and governance principles. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHidradenitis SuppurativaIndians, North AmericanPsoriasisIndigenous CanadiansHumansCanadaPrevalenceUnited States

Stichwörter der Autor:innen

IndigenousNorth Americaatopic dermatitisclinical trialshidradenitis suppurativapsoriasis

Autor:innen und Institutionen

  • Division of Dermatology, University of Saskatchewan, Regina, Saskatchewan, Canada.
  • Division of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Dermatology, University of Calgary, Calgary, Alberta, Canada.
  • Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Leslie and Irene Dubé Health Sciences Library, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Rachel Asiniwasis, Aysha Lukmanji, McKenzie Van Eaton, Eric McMullen, Dana Slape, Derek K Chu

Zitieren

APA

Asiniwasis, R., Roesler, J., Muftah, A., Lukmanji, A., Van Eaton, M., Yatham, K., Watson, E., McMullen, E., Kost, G., Jensen, C., Odeshi, O., Chacon, A., Slape, D., Waller, B., Hinther, K., Pandey, M., Jack, C., & Chu, D. K. (2026). Prevalence and Characteristics of North American Indigenous Inflammatory Skin Disease: A Systematic Scoping Review. International Journal of Dermatology, 65(12), 2476-2496. https://doi.org/10.1111/ijd.70470

Vancouver

Asiniwasis R, Roesler J, Muftah A, Lukmanji A, Van Eaton M, Yatham K, et al. Prevalence and Characteristics of North American Indigenous Inflammatory Skin Disease: A Systematic Scoping Review. International Journal of Dermatology. 2026;65(12):2476-2496. doi:10.1111/ijd.70470

BibTeX
@article{Asiniwasis2026,
  author = {Asiniwasis, Rachel and Roesler, Jordanna and Muftah, Amira and Lukmanji, Aysha and Van Eaton, McKenzie and Yatham, Kavya and Watson, Erin and McMullen, Eric and Kost, Gregory and Jensen, Colton and Odeshi, Oluwatosin and Chacon, Anna and Slape, Dana and Waller, Brittany and Hinther, Kelsey and Pandey, Mamata and Jack, Carolyn and Chu, Derek K},
  title = {Prevalence and Characteristics of North American Indigenous Inflammatory Skin Disease: A Systematic Scoping Review},
  journal = {International Journal of Dermatology},
  year = {2026},
  volume = {65},
  number = {12},
  pages = {2476--2496},
  doi = {10.1111/ijd.70470}
}
Kostenlos starten →